Skip to content

Plandai Biotechnology, Inc.: 10-Q/A filed 2013-06-06

What Plandai Biotechnology, Inc. reported in its quarterly report amendment filed 2013-06-06 (fiscal Q2 2013): 33 published measures, 77 facts as tagged in accession 0001262463-13-000363.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2013-06-06
Fiscal period
fiscal Q2 2013
Accession
0001262463-13-000363 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Plandai Biotechnology, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-318,752,825USD
At 2012-06-306,057,007USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-12-319,974,368USD
At 2012-06-306,346,542USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-31-1,221,543USD
At 2012-06-30-289,535USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-311,385,912USD
At 2012-06-305,112USD
At 2011-12-311,717USD
At 2011-06-30172USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-09-01 to 2012-12-31-504,327USD122
2012-07-01 to 2012-12-31-927,062USD184
2011-09-01 to 2011-12-31-70,074USD122
2011-07-01 to 2011-12-31-127,625USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-07-01 to 2012-12-31-705,102USD184
2011-07-01 to 2011-12-31-39,520USD184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-07-01 to 2012-12-31-885,285USD184
2011-07-01 to 2011-12-31-230USD184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-09-01 to 2012-12-31131,999USD122
2012-07-01 to 2012-12-31249,903USD184
2011-09-01 to 2011-12-3113,896USD122
2011-07-01 to 2011-12-3114,776USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-07-01 to 2012-12-313,387,005USD184
2011-07-01 to 2011-12-3141,295USD184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-07-01 to 2012-12-31-1,301,103USD184
2011-07-01 to 2011-12-31-230USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-12-31-8,815,738USD
At 2012-06-30-8,134,698USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-311,054,442USD
At 2012-06-30215,837USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-09-01 to 2012-12-31-435,984USD122
2012-07-01 to 2012-12-31-824,023USD184
2011-09-01 to 2011-12-31-70,074USD122
2011-07-01 to 2011-12-31-127,625USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-311,449,125USD
At 2012-06-3027,180USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-09-01 to 2012-12-31-68,343USD122
2012-07-01 to 2012-12-31-105,692USD184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-31341,302USD
At 2012-06-30100,481USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-12-3112USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-09-01 to 2012-12-31317,456USD122
2012-07-01 to 2012-12-31698,797USD184
2011-09-01 to 2011-12-3147,554USD122
2011-07-01 to 2011-12-3184,201USD184

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-09-01 to 2012-12-31-118,528USD122
2012-07-01 to 2012-12-31-125,226USD184
2011-09-01 to 2011-12-31-22,520USD122
2011-07-01 to 2011-12-31-43,424USD184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-09-01 to 2012-12-3122,919USD122
2012-07-01 to 2012-12-3123,514USD184

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-12-317,898,704USD
At 2012-06-307,894,278USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-12-31-5,147USD
At 2012-06-304,225USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2012-12-31-911,091USD
At 2012-06-30-225,105USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2012-12-317,319,289USD
At 2012-06-305,228,990USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-12-311,101,122USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-3146,680USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-12-3119,450USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-12-3155,189USD
At 2012-06-3028,219USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2012-09-01 to 2012-12-31-378,752USD122
2012-07-01 to 2012-12-31-690,412USD184
2011-09-01 to 2011-12-31-71,125USD122
2011-07-01 to 2011-12-31-128,676USD184

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-09-01 to 2012-12-3118,103USD122
2012-07-01 to 2012-12-31155,289USD184
2011-09-01 to 2011-12-3121,647USD122
2011-07-01 to 2011-12-3122,816USD184

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-09-01 to 2012-12-3131,817USD122
2012-07-01 to 2012-12-3146,680USD184
2011-07-01 to 2011-12-31119USD184

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2012-07-01 to 2012-12-312,653USD184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-07-01 to 2012-12-31-12USD184

Inspect the source

Entity
Plandai Biotechnology, Inc. / CIK 0001317880
Captured
SEC response SHA-256
e24b67d85b1d2e03527e4a75cf3f495a155375a1a0e10302aff7f4632fcf21aa

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001317880.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))